Printer Friendly

HMC Raising Awareness of Psoriasis to Dispel Common Misconceptions.

Hamad Medical Corporation (HMC) is creating awareness of psoriasis as part of its community outreach activities in recognition of Psoriasis Awareness Month this August. Through creating increased awareness about the autoimmune disease the healthcare organization is hoping to help dispel common misconceptions.

The main goal of Psoriasis Awareness Month is to raise awareness, encourage research and advocate for better care for individuals who have the disease. The month is also an opportunity to educate the public about the disease and to dispel common myths.

Psoriasis is a chronic, genetic autoimmune disease that causes red, scaly patches on the skin. Psoriasis changes the life cycle of skin cells. It causes cells to rapidly build up on the surface of the skin. It typically occurs on the knees, elbows, and scalp but can affect the torso, palms and soles of the feet or any other part of the skin.

Psoriasis is the most prevalent autoimmune disease in the United States affecting up to 7.5 million Americans. In Qatar, psoriasis affects approximately three percent of the country's population. Men and women develop psoriasis at equal rates. The condition is often diagnosed between the ages of 15 and 35, but it can develop at any age.

According to Dr. Ahmad Hazem Takiddin, Dermatology and Venereology Consultant at HMC, there are a number of common misconceptions about psoriasis, ranging from the condition being contagious to occurring due to poor hygiene. "Psoriasis is an autoimmune disease which affects the skin. The patches (plaques) can crack and bleed and this causes some people to think the condition is contagious. This is not true. Genetics and the immune system of a person play a vital role in the development of the disease. In those with psoriasis, the immune system sends abnormal signals that significantly accelerate the growth process of skin cells," explained Dr. Takiddin.

He emphasized that psoriasis is not caused or worsened by poor personal hygiene. "People with the disease have a genetic tendency to develop it. There are certain things that can trigger flare-ups, including skin injury, stress, hormonal changes, infections and some medications. Most people with the disease experience cycles of clear skin and outbreaks," he noted.

Dr. Takiddin added that many people with psoriasis don't know they have it because its symptoms are similar to skin rashes, making psoriasis difficult to diagnose. "Skin rashes are common so before making a psoriasis diagnosis doctors must rule out a list of other possible causes like food and medication allergies and viruses. Careful visual inspection is normally sufficient to diagnose psoriasis but sometimes a skin biopsy is required," he said.

While there is no cure for psoriasis, there are different treatments available to minimize the symptoms and control the disease. "Treatment is individualized from one person to another. Treatment options for psoriasis include creams and ointments applied to the skin, phototherapy (controlled exposure to certain types of ultraviolet light), and medication that reduces the production of skin cells," he highlighted.

Anyone concerned that they have developed psoriasis should make an appointment to see a primary care physician. In many cases, they will be able to prescribe effective treatment directly. However, more complex cases will be referred to a dermatology specialist.

For more information on psoriasis, including information on how to access HMC's dermatology specialist services, visit

[c] 2000 - 2017 Al Bawaba ( Provided by SyndiGate Media Inc. ( ).
COPYRIGHT 2017 SyndiGate Media Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2017 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Date:Aug 14, 2017
Previous Article:Bahrain Tourism and Exhibitions Authority Launches the Art of Content Management Course.
Next Article:GFH Records Net Profit Attributable to Shareholders of US$62 Million For the First Half of 2017.

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters